DrugPatentWatch Database Preview
Taro Pharm Company Profile
What is the competitive landscape for TARO PHARM, and what generic alternatives to TARO PHARM drugs are available?
There are six US patents protecting TARO PHARM drugs. There are two tentative approvals on TARO PHARM drugs.
There are twenty-nine patent family members on TARO PHARM drugs in thirteen countries and thirty-five supplementary protection certificates in eleven countries.
Summary for Taro Pharm
| International Patents: | 29 |
| US Patents: | 6 |
| Tradenames: | 48 |
| Ingredients: | 44 |
| NDAs: | 62 |
| Patent Litigation for Taro Pharm: | See patent lawsuits for Taro Pharm |
Drugs and US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds Ltd | HYDROCORTISONE | hydrocortisone | CREAM;TOPICAL | 086155-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharm Inds Ltd | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 040037-001 | Sep 30, 1994 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm | NYSTATIN | nystatin | SUSPENSION;ORAL | 062876-001 | Feb 29, 1988 | AA | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharms Ireland | ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE | ondansetron hydrochloride | INJECTABLE;INJECTION | 078014-001 | Mar 21, 2008 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Taro Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Taro Pharms | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ➤ Sign Up |
| Taro Pharms | TOPICORT | desoximetasone | SPRAY;TOPICAL | 204141-001 | Apr 11, 2013 | 5,990,100 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
Non-Orange Book US Patents for Taro Pharm
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 5,886,038 | Composition and method for treatment of psoriasis | ➤ Sign Up |
| 8,536,155 | Process for preparing malathion for pharmaceutical use | ➤ Sign Up |
| 8,957,238 | Process for preparing malathion for pharmaceutical use | ➤ Sign Up |
| 8,039,657 | Process for preparing malathion for pharmaceutical use | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Taro Pharm Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2003510259 | ➤ Sign Up |
| Israel | 188512 | ➤ Sign Up |
| Japan | 2012246315 | ➤ Sign Up |
| European Patent Office | 1888026 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB10/005 | United Kingdom | ➤ Sign Up | PRODUCT NAME: ADAPALENE AND BENZOYL PEROXIDE; REGISTERED: DK 40440 20071218; UK PL10590/0057 20091111 |
| 00085 | Netherlands | ➤ Sign Up | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 401 | Luxembourg | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
| 269 | Luxembourg | ➤ Sign Up | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
